This suggests not only the importance of NGF in decreasing the EAE lesions [141], but also offers new possibilities for increasing the anti-inflammatory potential of NGF in MS patients by removing these antibodies using TPE [142,143]. The gene discussed is NGF; the disease is myeloid sarcoma.